Jennifer Tousignant's Insider Trades & SAST Disclosures

Jennifer Tousignant's most recent trade in Viridian Therapeutics Inc was a trade of 124,072 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Viridian Therapeutics Inc
Jennifer Tousignant Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 124,072 124,072 - - Stock Option (Right to Buy)
Viridian Therapeutics Inc
Jennifer Tousignant Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 20,679 20,679 - - Restricted Stock Units
Viridian Therapeutics Inc
Jennifer Tousignant Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Feb 2024 290,000 290,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades